Fraser Institute

Recent papers from Fraser Institute

1. Risk of Retinopathy Associated with Long-Term Use of Hydroxychloroquine in Patients with Rheumatic Diseases: A Systematic Review and Meta-AnalysisThe Journal of Rheumatology · 2026
2. A worldwide cross-sectional survey seeks the current global practice patterns on perioperative management in elective shoulder replacement surgeryJSES International · 2026
3. Experiences and Perceptions Within a Co-Created Drone Transport Initiative With Rural First Nation and Non–First Nation Communities: Semistructured Interview StudyJournal of Participatory Medicine · 2026
4. Consequences of Canada’s Drug Agency Reimbursement Recommendations for New Medicines and Pan-Canadian Pharmaceutical Alliance Price Negotiations on Patient AccessClinicoEconomics and Outcomes Research · 2025
5. A scoping review of interventions for Hispanic caregivers of persons living with dementiaAlzheimer s & Dementia Behavior & Socioeconomics of Aging · 2025
6. A Semantic Framework for Neurosymbolic Computation (Abstract Reprint)2025
7. Interventions for cognitive frailty: developing a Delphi consensus with multidisciplinary and multisectoral expertsFrontiers in Aging Neuroscience · 2025
8. Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysisThe Lancet Neurology · 2025
9. Loperamide-induced severe cardiotoxicity: a toxicokinetic and toxicodynamic analysis derived from a case series and the published literatureClinical Toxicology · 2025
10. Mapping the Spatial Heterogeneity of Watershed Ecosystems and Water Quality in Rainforest FjordlandsEcosystems · 2025
11. Four Opportunities To Revitalize The US Biomedical Research EnterpriseHealth Affairs · 2025
12. Perceived cognitive loss, symptomology, and psychological well-being with bipolar disorderInternational Journal of Bipolar Disorders · 2024
13. Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure ModesMolecular Pharmaceutics · 2024
14. Is Canada Moving towards a More Agile Regulatory Approval and Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?Current Oncology · 2024
15. Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in CanadaClinicoEconomics and Outcomes Research · 2024
16. Orphan drugs approved in Canada: health technology assessment, price negotiation, and government formulary listingExpert Opinion on Orphan Drugs · 2024
17. Smoking cessation program preferences of individuals with chronic obstructive pulmonary disease: a qualitative studyPrimary Health Care Research & Development · 2024
18. Strategic pivoting: how organizations can shift attention whatever their sizeJournal of Business Strategy · 2023
19. Digital interventions for depression and anxiety in older adults: a systematic review of randomised controlled trialsThe Lancet Healthy Longevity · 2022
20. Lymphohistiocytic Myocarditis Possibly Due to Moderna mRNA-1273 VaccineAmerican Journal of Clinical Pathology · 2022